# Evaluation of Efficacy and Safety of Alcarisa (Hyaluronic Acid Produced by Espad Pharmed Co.) for Restoration of Mid-face Volume

> **NCT07126912** · NA · RECRUITING · sponsor: **Espad Pharmed** · enrollment: 30 (estimated)

## Conditions studied

- Mid Face Volume Deficit

## Interventions

- **DEVICE:** Alcarisa (hyaluronic acid filler)

## Key facts

- **NCT ID:** NCT07126912
- **Lead sponsor:** Espad Pharmed
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-28
- **Primary completion:** 2025-04-28
- **Final completion:** 2025-10-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07126912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07126912, "Evaluation of Efficacy and Safety of Alcarisa (Hyaluronic Acid Produced by Espad Pharmed Co.) for Restoration of Mid-face Volume". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07126912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*